Focus on MR safety

✍ Scribed by C. Leon Partain

• Publisher: John Wiley and Sons
• Year: 2007
• Tongue: English
• Weight: 36 KB
• Volume: 26
• Category: Article
• ISSN: 1053-1807
• DOI: 10.1002/jmri.21175

✦ Synopsis

This special issue is the second in a series of special issues on MR safety published in recent years by JMRI in an effort to encourage safety as a continuing primary commitment and to serve as a vehicle to document the scientific basis upon which safety decisions, protocols, and devices may be appropriately and safely developed and used. The previous special issue on MR safety was published in July 2000 (1).

It is notable that the recent concerns potentially linking gadolinium contrast agents with the serious complications of nephrogenic systemic fibrosis (NSF) prompted the Scientific Program Committee of the 2007 ISMRM/ESMRMB meeting in Berlin to establish and conduct an NSF workshop with international participation by scientists, clinicians, and regulatory agencies (2). This important symposium was organized, directed, and moderated by Georg Bongartz, MD, and Walter Kucharczyk, MD, and included invited speakers from international laboratories. A summary of this workshop is included in this special issue (3). It is important to call your attention also to the introduction to this safety issue prepared by recognized leaders in the field of MR safety, including Penny A